# LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/lncrna-dila1-inhibits-cyclin-d1-degradation-and-contributes-to-tamoxifen/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Qianfeng Shi,Yudong Li,Shunying Li,Liang Jin,Hongna Lai,Yanqing Wu,Zijie Cai,Mengdi Zhu,Qian Li,Ying Li,Jingru Wang,Yujie Liu,Zongqi Wu,Erwei Song,Qiang Liu |
| Citations | 195 |
| DOI | 10.1038/s41467-020-19349-w |
| Fields | Biochemistry, Genetics and Molecular Biology |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.nature.com/articles/s41467-020-19349-w.pdf |
| OpenAlex ID | https://openalex.org/W3097082103 |
| PMID | 33139730 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Yujie Liu](https://scholariq.org/researchers/yujie-liu/)

## Paper journal

- [Nature Communications](https://scholariq.org/journals/nature-communications/)

## Paper primary topic

- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)

## Paper topics

- [Cancer-related molecular mechanisms research](https://scholariq.org/topics/cancer-related-molecular-mechanisms-research/)
- [RNA Research and Splicing](https://scholariq.org/topics/rna-research-and-splicing/)
- [RNA modifications and cancer](https://scholariq.org/topics/rna-modifications-and-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.